Investigating the effects of dopamine on short‐ and long‐latency afferent inhibition
The Journal of Physiology · 2024
DOI: 10.1113/jp286126 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Physiology, 2024. Verfasst von Stevie D Foglia und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, McMaster University, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: Levodopa, Evoked Potentials, Motor, Transcranial Magnetic Stimulation, Carbidopa. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Short‐ and long‐latency afferent inhibition (SAI and LAI respectively) are phenomenon whereby the motor evoked potential induced by transcranial magnetic stimulation (TMS) is inhibited by a sensory afferent volley consequent to nerve stimulation. It remains unclear whether dopamine participates in the genesis or modulation of SAI and LAI. The present study aimed to determine if SAI and LAI are modulated by levodopa ( l ‐DOPA). In this placebo‐controlled, double‐anonymized study Apo‐Levocarb (100 mg l ‐DOPA in combination with 25 mg carbidopa) and a placebo were administered to 32 adult males (mean age 24 ± 3 years) in two separate sessions. SAI and LAI were evoked by stimulating the median nerve and delivering single‐pulse TMS over the motor hotspot corresponding to the first dorsal interosseous muscle of the right hand. SAI and LAI were quantified before and 1 h following ingestion of drug or placebo corresponding to the peak plasma concentration of Apo‐Levocarb. The results indicate that Apo‐Levocarb increases SAI and does not significantly alter LAI. These findings support literature demonstrating increased SAI following exogenous dopamine administration in neurodegenerative disorders. image Key points Short‐ and long‐latency afferent inhibition (SAI and LAI respectively) are measures of corticospinal excitability evoked using transcranial magnetic stimulation. SAI and LAI are reduced in conditions such as Parkinson's disease which suggests dopamine may be involved in the mechanism of afferent inhibition. 125 mg of Apo‐Levocarb (100 mg dopamine) increases SAI but not LAI. This study increases our understanding of the pharmacological mechanism of SAI and LAI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering, McMaster University, Hamilton, Ontario, Canada.
- Department of Kinesiology, McMaster University, Hamilton, Ontario, Canada.
- Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
- Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
ORCID-Profile: Mark Tarnopolsky, Jinhui Ma, Aimee J Nelson
Förderung
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Foglia, S. D., Adams, F. C., Ramdeo, K. R., Drapeau, C. C., Turco, C. V., Tarnopolsky, M., Ma, J., & Nelson, A. J. (2024). Investigating the effects of dopamine on short‐ and long‐latency afferent inhibition. The Journal of Physiology. https://doi.org/10.1113/jp286126
Vancouver
Foglia SD, Adams FC, Ramdeo KR, Drapeau CC, Turco CV, Tarnopolsky M, et al. Investigating the effects of dopamine on short‐ and long‐latency afferent inhibition. The Journal of Physiology. 2024. doi:10.1113/jp286126
BibTeX
@article{Foglia2024,
author = {Foglia, Stevie D and Adams, Faith C and Ramdeo, Karishma R and Drapeau, Chloe C and Turco, Claudia V and Tarnopolsky, Mark and Ma, Jinhui and Nelson, Aimee J},
title = {Investigating the effects of dopamine on short‐ and long‐latency afferent inhibition},
journal = {The Journal of Physiology},
year = {2024},
doi = {10.1113/jp286126}
}
EUVIMED